F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
support@thetaxheaven.com
F-14/15, Orbit Mall, Civil Lines, Jaipur-302006 support@thetaxheaven.comSenores Pharmaceuticals Ltd is an emerging player in India’s pharmaceutical sector, operating in a space driven by healthcare demand, export opportunities, and regulated market penetration. With rising healthcare awareness, increasing chronic disease prevalence, and strong global demand for affordable medicines, pharmaceutical companies are expected to remain structurally strong over the long term.
Backed by a balanced promoter holding, growing market capitalization, and expanding investor participation, Senores Pharmaceuticals Ltd has gained attention among mid-cap pharma stocks. In this article, we analyze Senores Pharmaceuticals Ltd share price targets from 2026 to 2030 based on current market data, sector outlook, and long-term growth drivers.
| Detail | Value |
|---|---|
| Open | ₹813.00 |
| Previous Close | ₹817.65 |
| Day’s High | ₹826.45 |
| Day’s Low | ₹809.05 |
| VWAP | ₹819.94 |
| 52-Week High | ₹876.50 |
| 52-Week Low | ₹440.30 |
| All-Time High | ₹876.50 |
| All-Time Low | ₹435.25 |
| Market Capitalization | ₹3,774 Cr |
| Volume | 65,943 |
| Value (Lacs) | ₹540.47 |
| Face Value | ₹10 |
| Book Value Per Share | ₹155.06 |
| Beta | 1.23 |
| UC Limit | ₹981.15 |
| LC Limit | ₹654.15 |
Senores Pharmaceuticals Ltd operates in the pharmaceutical manufacturing and formulation space, catering to domestic as well as export markets. The company focuses on delivering cost-effective, quality medicines, benefiting from India’s position as a global pharma manufacturing hub.
With India’s pharmaceutical industry expected to grow steadily due to exports, contract manufacturing, and rising domestic consumption, Senores Pharmaceuticals Ltd is positioned to leverage long-term healthcare demand.
Exposure to the structurally strong pharmaceutical sector
Rising demand for affordable generic medicines
Balanced promoter and public shareholding
Opportunities in export and regulated markets
Healthcare being a non-cyclical, defensive sector
The pharmaceutical sector continues to benefit from stable demand, export growth, and government focus on healthcare infrastructure. While margins can be influenced by regulatory pricing controls and raw material costs, companies with efficient operations and product diversification tend to perform well over time.
Senores Pharmaceuticals Ltd’s valuation reflects both growth expectations and sector stability, making it attractive for investors seeking a mix of growth and defensive exposure.
| Investor Type | Holding (%) |
|---|---|
| Promoters | 45.80% |
| Retail & Others | 41.54% |
| Mutual Funds | 4.88% |
| Other Domestic Institutions | 4.44% |
| Foreign Institutions | 3.35% |
A diversified shareholding pattern indicates increasing market participation, while promoter holding reflects continued management confidence.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2026 | 900 | 1,050 |
| 2027 | 1,080 | 1,260 |
| 2028 | 1,300 | 1,520 |
| 2029 | 1,550 | 1,820 |
| 2030 | 1,900 | 2,300 |
These projections are based on sector growth, earnings expansion, valuation re-rating, and increasing healthcare demand.
By 2026, stable revenue growth and improved operating efficiencies could support steady price appreciation.
Growth Drivers:
Consistent domestic pharma demand
Gradual expansion in exports
Investment View: Suitable for medium-term investors seeking stability.
2027 may reflect better margin visibility and broader product penetration.
Growth Drivers:
Scale benefits in manufacturing
Higher healthcare spending
Investment View: Positive outlook with moderate volatility.
By 2028, business diversification and stronger brand presence could drive earnings growth.
Growth Drivers:
Entry into regulated or semi-regulated markets
Improved cost control
Investment View: Strong candidate for long-term accumulation.
With India’s pharma exports expanding, Senores Pharmaceuticals Ltd could see sustained momentum.
Growth Drivers:
Export-led revenue growth
Stable cash flows from core formulations
Investment View: Favors long-term investors.
By 2030, the company could be valued as a well-established mid-cap pharmaceutical player.
Growth Drivers:
Long-term healthcare demand
Strong domestic and international presence
Investment View: Suitable for long-term wealth creation.
Senores Pharmaceuticals Ltd offers exposure to a defensive yet growing sector. While short-term stock movement may fluctuate due to regulatory or pricing pressures, the long-term outlook remains favorable.
Pharma sector’s non-cyclical demand
Growing healthcare consumption in India
Export opportunities supporting long-term growth
Regulatory pricing controls
Margin pressure from raw material costs
Competition in generic pharmaceuticals
Senores Pharmaceuticals Ltd stands as a promising mid-cap pharmaceutical company with stable fundamentals and long-term growth visibility. If execution remains consistent and sector conditions stay supportive, the stock could potentially trade in the range of ₹1,900 to ₹2,300 by 2030.
For investors looking to balance growth with defensive sector exposure, Senores Pharmaceuticals Ltd may offer attractive long-term potential.
1. What is the current share price of Senores Pharmaceuticals Ltd?
It trades near the levels mentioned in the latest market data table and fluctuates daily.
2. What is the expected share price target for 2026?
The projected range for 2026 is ₹900 to ₹1,050.
3. Is Senores Pharmaceuticals Ltd a good long-term investment?
It may suit investors seeking exposure to the pharmaceutical sector with moderate risk.
4. What is the share price target for 2030?
The estimated target range is ₹1,900 to ₹2,300.
5. What factors influence the share price the most?
Earnings growth, regulatory environment, export performance, and overall market sentiment.
Disclaimer:
This article is for educational purposes only and should not be considered financial advice. Pharmaceutical stocks involve regulatory and operational risks. Please consult a qualified financial advisor before investing.
Register & Login